Germany
# |
Name |
Gross Profit Margin |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
100.00%
|
Dec. 31, 2023 | USD 1.07 | -4.46% |
|
Germany |
|
2 |
100.00%
|
Dec. 31, 2023 | USD 1.33 | -6.34% |
|
Germany |
|
3 |
84.29%
|
Dec. 31, 2023 | USD 116.36 | -0.45% |
|
Germany |
|
4 |
72.77%
|
Dec. 31, 2023 | USD 1.09 | 3.54% |
|
Germany |
|
5 |
67.01%
|
Nov. 30, 2023 | USD 2.61 | 0.60% |
|
Germany |
|
6 |
58.54%
|
Dec. 31, 2023 | USD 20.20 | -1.60% |
|
Germany |
|
7 |
58.30%
|
Dec. 31, 2023 | USD 1.49 | -0.76% |
|
Germany |
|
8 |
56.91%
|
Dec. 31, 2023 | USD 5.29 | 13.28% |
|
Germany |
|
9 |
55.59%
|
Dec. 31, 2023 | USD 145.16 | 0.75% |
|
Germany |
|
10 |
47.28%
|
Dec. 31, 2023 | USD 48.95 | 1.72% |
|
Germany |
|
11 |
40.94%
|
Dec. 31, 2023 | USD 42.87 | 0.60% |
|
Germany |
|
12 |
39.01%
|
Dec. 31, 2023 | USD 4.96 | -2.24% |
|
Germany |
|
13 |
36.65%
|
Dec. 31, 2023 | USD 4.18 | 0.60% |
|
Germany |
|
14 |
33.90%
|
Dec. 31, 2023 | USD 49.86 | 0.81% |
|
Germany |
|
15 |
30.00%
|
Dec. 31, 2023 | USD 60.50 | -1.24% |
|
Germany |
|
16 |
26.65%
|
Dec. 31, 2023 | USD 18.55 | -3.93% |
|
Germany |
|
17 |
24.76%
|
Dec. 31, 2023 | USD 29.11 | 3.16% |
|
Germany |
|
18 |
24.25%
|
Dec. 31, 2023 | USD 21.54 | 1.09% |
|
Germany |
|
19 |
22.40%
|
Dec. 31, 2023 | USD 8.09 | -2.02% |
|
Germany |
|
20 |
6.27%
|
Sept. 30, 2023 | USD 3.68 | 1.46% |
|
Germany |
|
21 |
-119.76%
|
Dec. 31, 2023 | USD 5.97 | -4.48% |
|
Germany |
|
22 |
-131.34%
|
Dec. 31, 2023 | USD 3.95 | -0.95% |
|
Germany |
|
23 |
-743.67%
|
Dec. 31, 2023 | USD 2.34 | NA |
|
Germany |
The Biotechnology company in Germany with the highest Gross Profit Margin is Affimed N.V. (NasdaqGM: AFMD) at 100.00%.
The Biotechnology company in Germany with the lowest Gross Profit Margin is InflaRx N.V. (NasdaqGS: IFRX) at -743.67%.
The top 10 Biotechnology companies in Germany by Gross Profit Margin are Affimed N.V., Atai Life Sciences N.V., BioNTech SE, Medigene AG, Heidelberg Pharma AG, Bayer Aktiengesellschaft, NanoRepro AG, Mainz Biomed B.V., MERCK Kommanditgesellschaft auf Aktien and Eckert & Ziegler Strahlen- und Medizintechnik AG.
The bottom 10 Biotechnology companies in Germany by Gross Profit Margin are InflaRx N.V., CureVac N.V., Immatics N.V., BRAIN Biotech AG, Evotec SE, Nynomic AG, Stratec SE, technotrans SE, Formycon AG and GEA Group Aktiengesellschaft.